EMBS Webinar series: Three uses of Generative AI in Medicine: reducing radiation, measuring global burden of disease, and happily crossing ethical boundaries
Join us for the first webinar in the EMBS Twin Cities Engineering in Medicine series, sponsored by the IEEE Engineering in Medicine and Biology Society – Twin Cities Chapter.
This session will explore how generative AI tools—such as large language models and image generators—are beginning to reshape clinical care, research, and global health measurement. We will discuss how Denoising Diffusion Probabilistic Models (DDPM) can reduce radiation dose in breast imaging while preserving diagnostic quality, how synthetic data can help address bias and gaps in real‑world healthcare datasets, and how GenAI is being deployed to summarize medical visits and navigate complex electronic health records. The webinar will close with an open, interactive discussion on where these tools “happily cross ethical boundaries,” examining unresolved questions around safety, transparency, consent, and equity in and beyond healthcare.
Date and Time
Location
Hosts
Registration
-
Add Event to Calendar
Loading virtual attendance info...
- Contact Event Hosts
- Co-sponsored by Jamie Hamilton - from Southeastern Michigan EMBS chapter
Speakers
Fred Nugen of University of California - Berkley
Three uses of Generative AI in Medicine: reducing radiation, measuring global burden of disease
Generative AI includes tools like ChatGPT and ThisPersonDoesNotExist.com. These tools have many helpful applications, like using Denoising Diffusion Probabilistic Models (DDPM) to reduce radiation dose for breast cancer imaging. In addition, they can generate synthetic data to help reduce bias in healthcare datasets and fill gaps in real-world measurements. Helping summarize medical visits and investigate a patient's electronic health record is a newer usage of GenAI models being implemented in many hospitals around the world. While some people tout these innovations as efficiency tools, there are unresolved ethical implications in their use that most users and patients are unaware of, unable to resolve, or blithely ignore. We will explore the above uses of GenAI tools in the medical space, and close with an open-ended discussion of some of their ethical implications both inside and outside healthcare.
Biography:
Fred Nugen, PhD, is a Senior Collaborator with the Global Burden of Disease (GBD) Study. Prior to this, he was Assistant Professor of Radiology at Mayo Clinic in the Radiology AI Lab, specializing in AI models for diagnosis, prognosis, and screening of rare cancers. Since 2020, he has taught Data Science at UC Berkeley, leading the project-based Capstone course. His students have designed cutting-edge products, including a collaboration with the CDC for an AI model to help investigate breakouts of Legionnaire's disease, and a collaboration with Emergency Department at UC San Francisco hospital to detect unmilled procedures. Today, he is Chief AI Officer at Seirrowon, a startup specializing in centimeter-level GPS positioning systems for precision agriculture.
Agenda
1 hour of a virtual talk followed by questions.